And while most institutions understand the critical nature of glucose management, the “paper and pencil” protocols used in most hospitals today do not optimize insulin delivery to meet individual patient needs. This means that the critical need to quickly and safely manage hyperglycemia could go unmet.

Fortunately, there’s EndoTool, an FDA-cleared, clinically proven, leading-edge advanced software solution from Hospira. EndoTool:

• Provides truly personalized IV insulin dosing
• Reduces the variability of glycemic management by limiting the potential for human error, ensuring consistency, compliance and quality
• Frees up resources, increasing efficiency by providing data for improved decision making
• Offers comprehensive support from a trusted partner

Explore the rest of this site to learn more about:

• Issues related to hyperglycemia and its management
• How various protocols can affect insulin dosing, staff resources and cost
• Why EndoTool provides the best option for your patients, your staff and your hospital